title: Endpoint considerations for clinical trials.
authors.affiliation: Division of Clinical Trial Design and Analysis, Center for Biologics Evaluation and Research, FDA, USA.
authors.forename: Marc K
authors.initials: MK
authors.lastname: Walton
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D015203:Reproducibility of Results; D012107:Research Design; D009626:Terminology as Topic; D016896:Treatment Outcome